Diversity and U.S. Legal History

During the fall 2016 semester, a group of leading scholars came together at Harvard Law School for the lecture series, “Diversity and US Legal History,” which was sponsored by Dean Martha Minow and organized by Professor Mark Tushnet, who also designed a reading group to complement the lectures.

New Harvard report addresses legal and ethical factors affecting players’ health

The Football Players Health Study at Harvard University today released a set of legal and ethical recommendations to address a series of structural factors that affect NFL player health. The Football Players Health Study is a research initiative composed of several ongoing studies examining the health and wellbeing of NFL players.

Leading experts discuss why the time is right to transform advanced care

The Coalition to Transform Advanced Care (C-TAC), a non-profit organization with a vision of improving advanced illness care for all Americans, and the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School co-hosted the inaugural event for their new collaboration: The Project on Advanced Care and Health Policy.

Cohen: Supreme Court decision a ‘strong blow to the abortion restriction agenda’

Harvard Law School Professor I. Glenn Cohen, faculty director of the School’s Petrie-Flom Center for Health Law Policy, Biotechnology & Bioethics spoke with the Harvard Gazette about Monday’s ruling by the Supreme Court that overturned a Texas law requiring that abortion clinics maintain hospital-like standards at their facilities as well as admitting privileges at local hospitals.

Faculty Books In Brief—Spring 2016

“FDA in the 21st Century: The Challenges of Regulating Drugs and New Technologies,” edited by Holly Fernandez Lynch and I. Glenn Cohen ’03 (Columbia). Stemming from a 2013 conference at HLS, the book features essays covering major developments that have changed how the FDA regulates; how the agency encourages transparency; First Amendment issues; access to drugs; and evolving issues in drug-safety communication. These issues, the editors write, lie “at the heart of our health and health care.”

Harvard Law School launches the Campaign for the Third Century

With a nod to its historic past and a look ahead to its future, Harvard Law School has formally launched the Campaign for the Third Century, which seeks to raise $305 million in support of students and faculty, clinical education, new and innovative research, and the continued enhancement of the Law School campus.